These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25809890)

  • 1. Investment in antibiotics against pneumonia.
    Fernandes P
    Lancet Infect Dis; 2015 Apr; 15(4):376. PubMed ID: 25809890
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in mapping research investments for treatments against pneumonia.
    Head MG; Fitchett JR; Clarke SC
    Lancet Infect Dis; 2015 Nov; 15(11):1262. PubMed ID: 26531036
    [No Abstract]   [Full Text] [Related]  

  • 3. Investment in pneumonia and pneumococcal research.
    Head MG; Fitchett JR; Newell ML; Scott JAG; Clarke SC; Atun R
    Lancet Infect Dis; 2014 Nov; 14(11):1037-1038. PubMed ID: 25444398
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of the US priority review voucher on private-sector investment in global health research and development.
    Robertson AS; Stefanakis R; Joseph D; Moree M
    PLoS Negl Trop Dis; 2012; 6(8):e1750. PubMed ID: 22953004
    [No Abstract]   [Full Text] [Related]  

  • 5. Investment in training, evidence based treatment, and research are necessary to prevent future deaths in eating disorders.
    Ayton A
    BMJ; 2020 Dec; 371():m4689. PubMed ID: 33262109
    [No Abstract]   [Full Text] [Related]  

  • 6. Market watch: Evolution of Chinese bioclusters as a framework for investment policies in emerging markets.
    Gautam A
    Nat Rev Drug Discov; 2015 Jan; 14(1):8. PubMed ID: 25503337
    [No Abstract]   [Full Text] [Related]  

  • 7. Hwang scandal hits Korean biotech hard.
    Fuyuno I
    Nature; 2006 Jan; 439(7074):265. PubMed ID: 16421542
    [No Abstract]   [Full Text] [Related]  

  • 8. [Players from the program "Investments for the Future": MAbImprove MabEx].
    Larivière M; Pèlegrin A; Martineau P; Watier H
    Med Sci (Paris); 2019 Dec; 35(12):1204-1205. PubMed ID: 31903941
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing the value of America's investment in medical research.
    Hunt N
    MedGenMed; 2003 Jan; 5(1):34. PubMed ID: 12827095
    [No Abstract]   [Full Text] [Related]  

  • 10. Initiation of pneumococcal vaccine against pneumonia in Pakistan.
    Jamali T; Shahid A; Mistry R
    J Ayub Med Coll Abbottabad; 2013; 25(3-4):1-2. PubMed ID: 25226726
    [No Abstract]   [Full Text] [Related]  

  • 11. The toolbox is open, but who should pay for the job?
    Ladbury JE; Hall A; Skidmore J
    Nat Rev Drug Discov; 2014 Jul; 13(7):479-80. PubMed ID: 24981345
    [No Abstract]   [Full Text] [Related]  

  • 12. Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association.
    Hill JA; Ardehali R; Clarke KT; Del Zoppo GJ; Eckhardt LL; Griendling KK; Libby P; Roden DM; Sadek HA; Seidman CE; Vaughan DE;
    Circ Res; 2017 Jul; 121(3):e2-e8. PubMed ID: 28652256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal vaccination and childhood pneumonia in South Africa.
    Mulholland K; Nguyen C
    Thorax; 2015 Dec; 70(12):1103-5. PubMed ID: 26396133
    [No Abstract]   [Full Text] [Related]  

  • 14. Declining incidence of nonbacteremic pneumococcal pneumonia [corrected] in hospitalized elderly patients at a tertiary care hospital after the introduction of pneumococcal vaccines in Taiwan, 2004 to 2008.
    Lin SH; Tan CK; Lai CC; Wang CY; Hsueh PR
    J Am Geriatr Soc; 2010 Jan; 58(1):195-6. PubMed ID: 20122065
    [No Abstract]   [Full Text] [Related]  

  • 15. More severe pneumococcal pneumonia in hospitalized Uruguayan children.
    Fletcher MA
    J Pediatr; 2009 Feb; 154(2):307; author reply 307-8. PubMed ID: 19150682
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pneumococcal pneumonia: the particular case of aged patients in institutions].
    Trivalle C
    Rev Pneumol Clin; 2001 Feb; 57(1 Pt 2):64-6. PubMed ID: 11428238
    [No Abstract]   [Full Text] [Related]  

  • 17. NCI investment in nanotechnology: achievements and challenges for the future.
    Dickherber A; Morris SA; Grodzinski P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(3):251-65. PubMed ID: 25429991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine trial as "probe" to define the burden of pneumococcal pneumonia disease.
    Lucero MG; Williams G
    Lancet; 2005 Mar 26-Apr 1; 365(9465):1113-4. PubMed ID: 15794951
    [No Abstract]   [Full Text] [Related]  

  • 19. A preventable killer: Pneumonia.
    Klugman KP; ; Garau J;
    Clin Microbiol Infect; 2009 Nov; 15(11):989-90. PubMed ID: 19874383
    [No Abstract]   [Full Text] [Related]  

  • 20. Status of research and development of pediatric vaccines for Streptococcus pneumoniae.
    Alderson MR
    Vaccine; 2016 Jun; 34(26):2959-2961. PubMed ID: 27083428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.